Related content

Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome

By Chim C.  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 181-182

Springer Publishing Company

Access to resources Recommend Favorite

Clinical characteristics of a group of patients with multiple myeloma who had two different λ light chains by immunofixation electrophoresis: A retrospective study from a single center

By      

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-01 ,pp. : 1895-1900

Spandidos Publications

Access to resources Recommend Favorite

Novel agent induction therapy alone or followed by autologous stem cell transplantation in younger patients with multiple myeloma: A singlecenter retrospective study of 114 cases

By                

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 107-113

Science Publishers

Access to resources Recommend Favorite

The Implication of Compromised Renal Function at Presentation in Myeloma: Similar Outcome in Patients Who Receive High-Dose Therapy: A Single-Center Study of 251 Previously Untreated Patients

By Sirohi B.   Powles R.   Mehta J.   Treleaven J.   Raje N.   Kulkarni S.   Rudin C.   Bhagwati N.   Horton C.   Saso R.   Singhal S.   Parikh P.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 39-50

Humana Press, Inc

Access to resources Recommend Favorite

Effect of CYP2C19 and CYP3A4 gene polymorphisms on the efficacy of bortezomib-based regimens in patients with multiple myeloma

By          

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 1171-1175

Spandidos Publications

Access to resources Recommend Favorite